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A permanent tissue culture line of mouse lym-
phoma cells, S49. has been used to study the 
molecular mechanisms of action of cyclic AMP 
(cAMP) . These cells are derived from thymic 
lymphocytes. as evidenced by the presence of 
"theta" and TL (thymus leukemia) ant.igens. 
When S49 are t reated with the dibutyryl deriva-
tive of cAMP (dbcAMP) or with drugs that induce 
endogenous cAMP, such as isoproterenol. prosta-
glandin E l or cholera toxin, t he cells a re first 
inhibited in growth and then after several days a re 
killed [1]. Growth inhibition occurs in t he G 1 phase 
of the cell cycle and is rapid [2). The block can be 
reversed readi ly within t he fi rst day of treatment. 
The effectiveness of the block is a graded function 
of the concentration of dbcAMP. but even at 3 x 
10 - 3 M the block is only part ial. as shown by the 
presence of 5 to 10% of cells that at any given time 
have escaped from G 1 arrest and reentered the 
cycle. 
The initial period of growth arrest is followed in 2 
to 3 days by cytolysis. By cloning the cells in soft 
agar with dbcAMP, mutants resistant to growth 
inhibition or cytolysis are obtained [3,4 ). The mu-
tations occur spontaneously at a rate of about 
2 x 10- ' / cell/generation . The frequency is in-
creased by treatment with mutagens such as 
nitrosoguanidine or the acridine half mustard ICR 
191. More than 200 mutants selected in this way 
have t hus fa r been examined ; compared to wild 
type parents, they uniformly have defects in 
cAMP-dependent protein kinase. 
In vitro assays of kinase and cAMP-bindi ng 
activity have revealed t hree classes of mutants [5 ). 
The most common contains reduced amounts of 
apparen tly structurally normal kinase. The second 
most common has no detectable kinase or binding 
activity. Members of the smallest. class, of which 
we now have three independent examples, appear 
to produce a normal amount of structurally alte red 
kinase. These have a decreased affinity for cAMP 
in vitro and a correspondingly altered dose-
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response for dbcAMP in whole cells, requiring a 10-
to 20-fold higher concen trat ion for half maximal 
induction of growth arrest, cell death, and phos-
phodiesterase induction. The close parallelism 
between kinase activity in vitro and biologic re-
sponse of whole cells holds for wild type and all 
classes of mutant.s. This demonstrates that cAMP 
mediates each of these three biologic fu nctions by 
activating kinase. One piece of evidence support-
ing the structural nature of the kinase mutants 
with altered cAMP affinity is t he a ltered thermal 
lability of their enzyme activity compared with wild 
type. In one of these mutants, we have been able to 
localize the defect to t he regula tory su bunit of 
kinase by examining the properties of homologous 
and heterologous enzyme reconstit uted from t he 
purified regulatory and catalyt ic su bunits of wild 
type and mutant enzyme (6). 
We conclude from these studies that kinase 
plays a central role in cAMP-mediated effects. It 
appears likely that this system will also prove 
useful in somatic genetic studies, particularly in 
examining the nature of gene mutation and regula-
tion in animal cells. The physiologic role of cAMP-
induced cell death is unclear. We are exploring the 
question of whether th is represents an analog of 
processes that. occur in the course of normal 
thymocyte maturation. 
The S49 cells are also subject to cytolysis by 
glucocorticoids. By selection with dexamethasone, 
analogous mutants resistant to glucocorticoid-
induced death have been obtained. T hese are 
defective in the cytoplasmic glucocorti coid binding 
protein. In wild type cells , as in other glucocor-
ticord-responsive systems, the dexamethasone· 
recept.or complex forms in the cytoplasm and is 
then t ransported to the nucleus. Sibley and Tom -
kins [7,8] have shown that dexamethasone- resist-
ant S49 cells have absent binding activity, or else 
quantitative changes in the degree of n uclear 
t ransport and binding. Interestingly there is no 
cross- resistance in mutants selected for either 
dbcAMP or dexamethasone resistance alone. Dou-
bly resistant mutants can be selected, Their inci-
dence is the produc t of the incidence of mutants 
resistant to each agent alone, i.e ., if p is the 
incidence of a mutant, then p [cAR]xp [dex RJ = 
P rcA R,dex R). This shows that no mutable step is 
common to cAMP and glucocorticoid-induced cy-
tolysis. 
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